📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult. (2017)

First Author: Morris EC

Attributed to: Phase I/II trial of lentiviral vector mediated gene therapy for Adenosine Deaminase deficiency funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2017-04-777136

PubMed Identifier: 28716862

Publication URI: http://europepmc.org/abstract/MED/28716862

Type: Journal Article/Review

Volume: 130

Parent Publication: Blood

Issue: 11

ISSN: 0006-4971